These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8182419)

  • 21. The use of one-sided tests in drug trials: an FDA advisory committee member's perspective.
    Fisher LD
    J Biopharm Stat; 1991; 1(1):151-6. PubMed ID: 1844686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study nurses in Germany--a survey of job-related activities in clinical trials as a basis for a job description and for training curricula].
    Fisk B; Beier J
    Pflege; 2007 Oct; 20(5):293-9. PubMed ID: 18214221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. US Food and Drug Administration Clinical Investigator Inspections.
    Buchmeier AD
    Semin Oncol Nurs; 2020 Apr; 36(2):151000. PubMed ID: 32253049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug Development, Trial Design, and Endpoints in Oncology: Adapting to Rapidly Changing Science.
    Blumenthal GM; Goldberg KB; Pazdur R
    Clin Pharmacol Ther; 2017 May; 101(5):572-574. PubMed ID: 28074476
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How to access and process FDA drug approval packages for use in research.
    Turner EH
    BMJ; 2013 Oct; 347():f5992. PubMed ID: 24126858
    [No Abstract]   [Full Text] [Related]  

  • 26. Clinical trial quality: From supervision to collaboration and beyond.
    Meeker-O'Connell A; Glessner C
    Clin Trials; 2018 Feb; 15(1_suppl):23-26. PubMed ID: 29452521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical Trials in a Dish.
    Strauss DG; Blinova K
    Trends Pharmacol Sci; 2017 Jan; 38(1):4-7. PubMed ID: 27876286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulatory issues with multiplicity in drug approval: Principles and controversies in a changing landscape.
    Benda N; Brandt A
    J Biopharm Stat; 2018; 28(1):3-9. PubMed ID: 29065277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The concept of clinical availability: an industry perspective.
    Citron P
    ASAIO J; 1997; 43(6):878-9. PubMed ID: 9386833
    [No Abstract]   [Full Text] [Related]  

  • 30. Who holds the baby in the neonatal unit?
    Rea J
    Br J Nurs; 1996 Jul 11-24; 5(13):817-21. PubMed ID: 8974529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical research and the development of new devices: considerations for nurses.
    Lanter J
    Dimens Crit Care Nurs; 2007; 26(3):117-20. PubMed ID: 17440296
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pivotal trials of orthopedic surgical devices in the United States: predominance of two-arm non-inferiority designs.
    Golish SR
    Trials; 2017 Jul; 18(1):348. PubMed ID: 28738891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using the MADIT II criteria for implantable cardioverter defibrillators-what is the role of the Food and Drug Administration approval?
    Barold HS
    Card Electrophysiol Rev; 2003 Dec; 7(4):443-6. PubMed ID: 15071272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FDA perspective on clinical trial design for cardiovascular devices.
    Chen E; Sapirstein W; Ahn C; Swain J; Zuckerman B
    Ann Thorac Surg; 2006 Sep; 82(3):773-5. PubMed ID: 16928481
    [No Abstract]   [Full Text] [Related]  

  • 35. Role of the FDA in cancer therapy research.
    Young RS
    Semin Oncol; 1981 Dec; 8(4):447-52. PubMed ID: 7323818
    [No Abstract]   [Full Text] [Related]  

  • 36. The placebo control in clinical trials (a view from the FDA).
    Leber P
    Psychopharmacol Bull; 1986; 22(1):30-2. PubMed ID: 3726077
    [No Abstract]   [Full Text] [Related]  

  • 37. Clinical trials: the role of the neuroscience nurse.
    Hodges LC; Patterson R; Rapp CG
    J Neurosci Nurs; 1990 Jun; 22(3):195-8. PubMed ID: 2142195
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer Center Launched Within FDA.
    Voelker R
    JAMA; 2017 Mar; 317(9):900. PubMed ID: 28267838
    [No Abstract]   [Full Text] [Related]  

  • 39. How to use FDA drug approval documents for evidence syntheses.
    Ladanie A; Ewald H; Kasenda B; Hemkens LG
    BMJ; 2018 Jul; 362():k2815. PubMed ID: 29991565
    [No Abstract]   [Full Text] [Related]  

  • 40. FDA workshop on clinical trial design, September 6-7--registration by Aug. 18. Food and Drug Administration.
    James JS
    AIDS Treat News; 1995 Aug; (no 228):5-6. PubMed ID: 11362627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.